141 related articles for article (PubMed ID: 28560594)
1. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
[TBL] [Abstract][Full Text] [Related]
2. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
3. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
[TBL] [Abstract][Full Text] [Related]
4. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
[TBL] [Abstract][Full Text] [Related]
5. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
6. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
[TBL] [Abstract][Full Text] [Related]
7. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
[TBL] [Abstract][Full Text] [Related]
8. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
9. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
[TBL] [Abstract][Full Text] [Related]
10. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
[TBL] [Abstract][Full Text] [Related]
11. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
13. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
14. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
15. Expression of sushi domain containing two reflects the malignant potential of gastric cancer.
Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
18. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.
Shimizu D; Kanda M; Tanaka H; Kobayashi D; Tanaka C; Hayashi M; Iwata N; Niwa Y; Takami H; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
Sci Rep; 2017 Feb; 7():42089. PubMed ID: 28165032
[TBL] [Abstract][Full Text] [Related]
19. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
20. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]